Valuation: Oscotec Inc.

Market Cap 1,329B 989M 883M 820M 746M 1.4B 93.67B 1.43B 9.86B 3.86B 48.87B 3.71B 3.63B 156B P/E 2026 *
41.3x
P/E 2027 * 11.1x
Enterprise Value 1.14B 851K 760K 706K 642K 1.21M 80.64M 1.23M 8.48M 3.32M 42.07M 3.19M 3.13M 135M EV / Sales 2026 *
13.6x
EV / Sales 2027 * 5.34x
Free-Float
72.01%
Yield 2026 *
-
Yield 2027 * -
1 day-2.93%
1 week-7.82%
Current month-2.52%
1 month+0.43%
3 months+13.75%
6 months-39.25%
Current year-23.12%
1 week 34,150
Extreme 34150
37,850
1 month 34,150
Extreme 34150
40,850
Current year 27,300
Extreme 27300
60,200
1 year 27,300
Extreme 27300
66,000
3 years 18,000
Extreme 18000
66,000
5 years 15,850
Extreme 15850
66,000
10 years 5,630
Extreme 5630
71,500
Manager TitleAgeSince
Chief Executive Officer 64 2020-03-25
Corporate Officer/Principal 54 1999-08-31
Chief Tech/Sci/R&D Officer 63 -
Director TitleAgeSince
Director/Board Member 54 1999-08-31
Director/Board Member 64 2020-03-25
Director/Board Member 66 2023-03-29
Date Insider Type Main position Quantity % Market Cap. Importance
7/24/25 Buy 500 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-2.93%-7.82%-16.47%+28.23% 989M
+3.55%+7.01%+51.42%+105.45% 1,116B
-0.25%-1.25%+32.49%+61.48% 610B
-0.03%+4.03%+25.28%+91.54% 501B
-1.48%+1.97%+72.62%+39.59% 358B
-0.86%+5.51%+32.32%+49.71% 366B
-1.08%+4.84%+19.67%+43.19% 288B
-1.58%+4.47%-0.16%+14.24% 261B
+1.86%+6.53%+45.98%+52.77% 235B
+2.49%+6.98%+33.03%+102.67% 195B
Average -0.01%+3.96%+29.62%+58.89% 393.08B
Weighted average by Cap. +0.81%+4.93%+38.30%+71.74%

Financials

2026 *2027 *
Net sales 84B 62.49M 55.78M 51.84M 47.15M 88.72M 5.92B 90.31M 623M 244M 3.09B 235M 230M 9.88B 192B 143M 127M 118M 108M 203M 13.53B 206M 1.42B 557M 7.06B 536M 525M 22.59B
Net income 32B 23.81M 21.25M 19.75M 17.96M 33.8M 2.25B 34.41M 237M 92.82M 1.18B 89.33M 87.44M 3.76B 119B 88.53M 79.02M 73.44M 66.8M 126M 8.38B 128M 882M 345M 4.37B 332M 325M 14B
Net Debt -185B -138M -123M -114M -104M -195M -13.03B -199M -1.37B -537M -6.8B -516M -506M -21.76B -304B -226M -202M -188M -171M -321M -21.42B -327M -2.25B -882M -11.18B -849M -831M -35.76B
Projected Income Statement - Annual - Oscotec Inc.
Logo Oscotec Inc.
Oscotec Inc is a Korea‑based company primarily engaged in new drug development business. The Company operates four main businesses. The new drug development business primarily mainly researches and develops synthetic new drugs, including therapies for autoimmune diseases, acute myeloid leukemia, refractory solid tumors, Alzheimer’s disease and next‑generation solid tumor treatments designed to overcome drug resistance. The dental bone graft business primarily supplies bone graft materials. The dental barrier membrane business provides own developed absorbable collagen barrier membranes. The functional materials and related products business primarily provide functional materials for osteoporosis prevention and bone health, materials and finished products for arthritis prevention and alleviation, and functional materials for periodontal disease prevention and alleviation.
Employees
57
Date Price Change Volume
26-10-15 ₩34,750.00 -2.93% 97,900
26-10-14 ₩35,800.00 +1.27% 98,066
26-10-13 ₩35,350.00 -3.15% 110,874
26-10-12 ₩36,500.00 -3.18% 77,284
26-10-08 ₩37,700.00 -5.04% 120,779
Trader
Investor
-
Global
-
Quality
ESG MSCI
CCC
MarketScreener Ratings - Oscotec Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
34,750.00KRW
Average target price
75,000.00KRW
Spread / Average Target
+115.83%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Oscotec Inc.
  1. Stock Market
  2. Stocks
  3. A039200 Stock